Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood

Journal of Infectious Diseases

Volumn 193, Issue 7, 2006, Pages 1005-1013

  Malhotra, Indu ^a   Mungai, Peter L ^a   Wamachi, Alex N ^c   Tisch, Daniel ^a   Kioko, John M ^b   Ouma, John H ^d   Muchiri, Eric ^b   Kazura, James W ^a   King, Christopher L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Vector Borne Diseases   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d KENYATTA UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

FILARIA ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FILARIA; FILARIASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION RISK; INFECTION SENSITIVITY; KENYA; LYMPHOCYTE; MAJOR CLINICAL STUDY; PARASITE IMMUNITY; PREGNANCY COMPLICATION; PRENATAL PERIOD; PRIORITY JOURNAL; SENSITIZATION; UMBILICAL CORD BLOOD; WUCHERERIA BANCROFTI;

ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; FILARIASIS; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-5; PARASITEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; T-LYMPHOCYTES; WUCHERERIA BANCROFTI;

EID: 33645364423     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500472     Document Type: Article

References (45)

1. Michael E, Bundy DA, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112(Pt 4):409-28.
2. Ottesen EA. The Wellcome Trust Lecture. Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology 1992; 104(Suppl):S71-9.
3. Kazura JW, Bockarie M, Alexander N, et al. Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. J Infect Dis 1997; 176:242-6.
4. Tobian AA, Tarongka N, Baisor M, Bockarie M, Kazura JW, King CL. Sensitivity and specificity of ultrasound detection and risk factors for filarial-associated hydroceles. Am J Trop Med Hyg 2003; 68:638-42.
5. Choi EH, Nutman TB, Chanock SJ. Genetic variation in immune function and susceptibility to human filariasis. Expert Rev Mol Diagn 2003; 3:367-74.
6. Dreyer G, Noroes J, Figueredo-Silva J, Piessens WF. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 2000; 16:544-8.
7. Nutman TB, Kumaraswami V. Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol 2001; 23:389-99.
8. Alexander ND, Kazura JW, Bockarie MJ, et al. Parental infection confounded with local infection intensity as risk factors for childhood microfilaraemia in bancroftian filariasis. Trans R Soc Trop Med Hyg 1998; 92: 23-4.
9. Lammie PJ, Hitch WL, Walker Allen EM, Hightower W, Eberhard ML. Maternal filarial infection as risk factor for infection in children. Lancet 1991; 337:1005-6.
10. Malhotra I, Ouma JH, Wamachi A, et al. Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in Kenya. Infect Immun 2003; 71:5231-7.
11. Partono F, Pribadi PW, Soewarta A. Epidemiological and clinical features of Brugia timori in a newly established village: Karakuak, West Flores, Indonesia. Am J Trop Med Hyg 1978; 27:910-5.
12. Partono F, Purnomo. Clinical features of timorian filariasis among immigrants to an endemic area in West Flores, Indonesia. Southeast Asian J Trop Med Public Health 1978; 9:338-43.
13. Dissanayake S, de Silva LV, Ismail MM. IgM antibody to filarial antigens in human cord blood: possibility of transplacental infection. Trans R Soc Trop Med Hyg 1980; 74:542-4.
14. King CL, Malhotra I, Mungai P, et al. B cell sensitization to helminthic infection develops in utero in humans. J Immunol 1998; 160:3578-84.
15. Malhotra I, Ouma J, Wamachi A, et al. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest 1997; 99:1759-66.
16. Weil GJ, Hussain R, Kumaraswami V, Tripathy SP, Phillips KS, Ottesen EA. Prenatal allergic sensitization to helminth antigens in offspring of parasite-infected mothers. J Clin Invest 1983; 71:1124-9.
17. Steel C, Guinea A, McCarthy JS, Ottesen EA. Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens. Lancet 1994; 343:890-3.
18. More SJ, Copeman DB. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitai 1990; 41:403-6.
19. Eberhard ML, Lammie PJ. Laboratory diagnosis of filariasis. Clin Lab Med 1991; 11:977-1010.
20. Helmy H, Weil GJ, Faris R, et al. Human antibody responses to Wuchereria bancrofti infective larvae. Parasite Immunol 2000; 22:89-96.
21. Malhotra I, Mungai P, Muchiri E, et al. Distinct Th1- and Th2-type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun 2005; 73:3462-70.
22. Terhell AJ, Houwing-Duistermaat JJ, Ruiterman Y, Haarbrink M, Abadi K, Yazdanbakhsh M. Clustering of Brugia malayi infection in a community in South-Sulawesi, Indonesia. Parasitology 2000; 120:23-9.
23. Romia SA, el-Ganayni GA, Makhlouf LM, Handousa AE. HLA antigens and blood groups in bancroftian filariasis. J Egypt Soc Parasitol 1988; 18: 211-20.
24. Choi EH, Zimmerman PA, Foster CB, et al. Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun 2001; 2:248-53.
25. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353:196-200.
26. Le Goff L, Loke P, Ali HF, Taylor DW, Allen JE. Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite. Infect Immun 2000; 68:2513-7.
27. Volkmann L, Bain O, Saeftel M, et al. Murine filariasis: interleukin 4 and interleukin 5 lead to containment of different worm developmental stages. Med Microbiol Immunol (Berl) 2003; 192:23-31.
28. Martin C, Al-Qaoud KM, Ungeheuer MN, et al. IL-5 is essential for vaccine-induced protection and for resolution of primary infection in murine filariasis. Med Microbiol Immunol (Berl) 2000; 189:67-74.
29. King CL, Kumaraswami V, Poindexter RW, et al. Immunologic tolerance in lymphatic filariasis: diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest 1992; 89: 1403-10.
30. Babu S, Kumaraswami V, Nutman TB. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes. Infect Immun 2005; 73:3394-401.
31. Gillan V, Devaney E. Regulatory T cells modulate Th2 responses induced by Brugia pahangi third-stage larvae. Infect Immun 2005; 73: 4034-42.
32. Taylor MD, LeGoff L, Harris A, Malone E, Allen JE, Maizels RM. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 2005; 174: 4924-33.
33. Dimock KA, Eberhard ML, Lammie PJ. Th1-like antifilarial immune responses predominate in antigen-negative persons. Infect Immun 1996; 64:2962-7.
34. Ravindran B, Satapathy AK, Sahoo PK, Mohanty MC. Protective immunity in human lymphatic filariasis: problems and prospects. Med Microbiol Immunol (Berl) 2003; 192:41-6.
35. Paciorkowski N, Shultz LD, Rajan TV. Primed peritoneal B lymphocytes are sufficient to transfer protection against Brugia pahangi infection in mice. Infect Immun 2003; 71:1370-8.
36. Partono F, Oemijati S. The association of clinical filariasis and Wuchereria bancrofti infections in Jakarta. Southeast Asian J Trop Med Public Health 1978; 9:260-3.
37. Nielsen NO, Bloch P, Simonsen PE. Lymphatic filariasis-specific immune responses in relation to lymphoedema grade and infection status. II. Humoral responses. Trans R Soc Trop Med Hyg 2002; 96:453-8.
38. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993; 168:1000-8.
39. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991; 349:243-5.
40. Campello TR, Ferreira RS, Pires ML, et al. A study of placentas from Wuchereria bancrofti microfilaraemic and amicrofilaraemic mothers. J Trop Med Hyg 1993; 96:251-5.
41. Eberhard ML, Hitch WL, McNeeley DF, Lammie PJ. Transplacental transmission of Wuchereria bancrofti in Haitian women. J Parasitol 1993; 79: 62-6.
42. Hitch WL, Eberhard ML, Lammie PJ. Investigation of the influence of maternal infection with Wuchereria bancrofti on the humoral and cellular responses of neonates to filarial antigens. Ann Trop Med Parasitol 1997; 91:461-9.
43. Ramzy RM, Gad AM, Faris R, Weil GJ. Evaluation of a monoclonal-antibody based antigen assay for diagnosis of Wuchereria bancrofti infection in Egypt. Am J Trop Med Hyg 1991; 44:691-5.
44. Crocker IP, Tanner OM, Myers JE, Bulmer JN, Walraven G, Baker PN. Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. Placenta 2004; 25:273-82.
45. Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health 2000; 5:591-4.